HCA Healthcare (NYSE:HCA) Price Target Raised to $400.00 at Oppenheimer

by · The Cerbat Gem

HCA Healthcare (NYSE:HCA – Free Report) had its price target lifted by Oppenheimer from $390.00 to $400.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have an outperform rating on the stock.

A number of other research firms have also commented on HCA. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. KeyCorp lowered their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Leerink Partners raised their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $379.11.

Get Our Latest Analysis on HCA

HCA Healthcare Price Performance

HCA stock opened at $356.63 on Monday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare has a 1 year low of $222.23 and a 1 year high of $417.14. The company has a 50 day simple moving average of $394.71 and a 200 day simple moving average of $352.94. The stock has a market cap of $93.41 billion, a price-to-earnings ratio of 17.78, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling

In related news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently modified their holdings of HCA. CreativeOne Wealth LLC bought a new position in HCA Healthcare in the 1st quarter worth about $231,000. Bessemer Group Inc. increased its position in shares of HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Empowered Funds LLC increased its position in shares of HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the last quarter. Swedbank AB purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at about $95,882,000. Finally, EP Wealth Advisors LLC increased its position in shares of HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock valued at $72,335,000 after purchasing an additional 3,516 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles